Trial record 1 of 1 for:    belviq phentermine
Previous Study | Return to List | Next Study

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01987427
Recruitment Status : Completed
First Posted : November 19, 2013
Last Update Posted : January 26, 2015
Information provided by (Responsible Party):
Eisai Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2014
  Actual Study Completion Date : September 2014